InfexnTM | UPSC

InfexnTM mind map
Recent News
India's First Genomics-based Infectious Diseases Test
Introduced in Thiruvananthapuram
When
Announced on February 09, 2024
Why
Enhance Infectious Disease Detection
Promote Antimicrobial Stewardship
What
State-of-the-art Genomic Test
Detect Bacterial, Fungal Infections
Identify Antimicrobial Resistance Genes
Timeframe
Results within 24 Hours
Components
Kit and Software Solution
Made in India
Global Relevance
Where
NIMS Medicity, Neyyattinkara
Super Specialty Hospital
Who
HaystackAnalytics
Genomics Diagnostics Solutions Provider
NIMS Medicity
Thiruvananthapuram-based Hospital
Dr Aneesh Nair
Principal Scientist & Head, NIMS Centre for Genomic Medicine
Dr Mahua Dasgupta Kapoor
Director, Medical Affairs (Infectious Diseases), HaystackAnalytics
How
On-site Genomic Testing
Advanced Genome Sequencing Technology
Significance
Accurate Infection Diagnostics
Tailored Antibiotic Usage
Enhancing Healthcare Ecosystem
Aligning with India's Antimicrobial Resistance Commitment
Way Forward
Expand Collaboration with Hospitals
Empower Medical Practitioners
Improve Patient Care with Precise Diagnosis

InfexnTM, introduced in Kerala’s capital, Thiruvananthapuram, is India’s first genomics-based infectious diseases test. Developed by HaystackAnalytics in collaboration with NIMS Medicity, this state-of-the-art test can detect bacterial and fungal infections, as well as antimicrobial resistance genes within 24 hours. This initiative promises to revolutionize the diagnosis and treatment of infectious diseases, aligning with India’s commitment to fight antimicrobial resistance. It symbolizes a significant advancement in the healthcare sector, enhancing patient care through precise diagnosis and tailored antibiotic usage.